RESEARCH & DEVELOPMENT
Patents & Intellectual Property
SAB Biotherapeutics has a strong patent position with 12 patent families. The company’s broad portfolio includes
more than 50 issued patents and applications globally with platform protection through 2032.
- Granted patent protection of human antibody in ungulates
- Human artificial chromosome (HAC)
- Somatic cell sequential gene targeting (SCSGT)
- Chromatin transfer (CT)